These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3113299

  • 1. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I, Alessi MC, Aillaud MF.
    Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
    [Abstract] [Full Text] [Related]

  • 2. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I, Aillaud MF, Valadier J, Alessi MC, Serradimigni A.
    Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
    [Abstract] [Full Text] [Related]

  • 3. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.
    Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [Abstract] [Full Text] [Related]

  • 4. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH, Rijken DC, Chang GT, Preston FE, Kluft C.
    Thromb Haemost; 1984 Jul 29; 51(3):396-7. PubMed ID: 6437007
    [Abstract] [Full Text] [Related]

  • 5. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED, Akkerman JW, Jansen BG.
    Thromb Haemost; 1986 Jun 30; 55(3):325-9. PubMed ID: 3092389
    [Abstract] [Full Text] [Related]

  • 6. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED.
    Thromb Haemost; 1986 Feb 28; 55(1):74-7. PubMed ID: 3085268
    [Abstract] [Full Text] [Related]

  • 7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 8. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J, Rueda F.
    Sangre (Barc); 1985 Dec 22; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract] [Full Text] [Related]

  • 9. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 10. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
    Aillaud MF, Pignol F, Alessi MC, Harle JR, Escande M, Mongin M, Juhan-Vague I.
    Thromb Haemost; 1986 Jun 30; 55(3):330-2. PubMed ID: 3092390
    [Abstract] [Full Text] [Related]

  • 11. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
    Brommer EJ, Verheijen JH, Chang GT, Rijken DC.
    Thromb Haemost; 1984 Oct 31; 52(2):154-6. PubMed ID: 6441302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
    Mellbring G, Dahlgren S, Wiman B.
    Acta Chir Scand; 1985 Oct 31; 151(2):109-14. PubMed ID: 3873768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA, Alfaro MJ, Rocha E.
    Thromb Haemost; 1985 Oct 30; 54(3):713-6. PubMed ID: 3937269
    [Abstract] [Full Text] [Related]

  • 19. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
    Booth NA, Reith A, Bennett B.
    Thromb Haemost; 1988 Feb 25; 59(1):77-9. PubMed ID: 3129811
    [Abstract] [Full Text] [Related]

  • 20. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D.
    Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.